Patients with colon cancer using GLP-1 receptor agonists (the class of drugs behind treatments like Ozempic, Wegovy, and ...

Colorectal cancer is one of the leading causes of cancer death worldwide. In recent years, immunotherapies—treatments that ...

A man in his seventies developed fulminant capecitabine toxicity despite normal DPYD screening, revealing a rare variant that ...

The study found that the five-year mortality rate was significantly lower among patients who were using GLP-1 receptor ...

Recovering from colon cancer treatment is not just about healing physically, but rebuilding strength, improving digestion and ...

Dr. Joshua Sabari sat down with Dr. Michael Cecchini to discuss advances in colorectal cancer management and key data ...

A new study, with help from artificial intelligence, focuses on reprogramming cancer stem cells and triggering some to ...

"Not all colon polyps are cancerous but all colon cancer starts as a polyp which is why everyone needs to know about them and ...

The U.S. Food and Drug Administration has granted Fast Track Designation to a new drug combination for metastatic colorectal ...

Twenty years of updates in technology, techniques and available medications has provided more hope for patients with colorectal cancer, with more advances on the horizon. Over the past 20 years, ...

This thesis investigates less invasive treatments for large colon polyps and early-stage colon cancer. The focus on a new technique: the colonoscopy-assisted laparoscopic wedge resection (CAL-WR).

Immunotherapy uses the power of your immune system to fight your cancer. One type of immunotherapy is called an immune checkpoint inhibitor. Your immune system has built-in checkpoints that help it ...